erlotinib: 15 Real Stories
15 stories match erlotinib. 5 of them mention osimertinib.
Stage IV Non-Small Cell Lung Cancer: Tomma’s Patient Story
Tomma Hargraves noticed a small bump on the left side of her neck in October 2006. A biopsy led to a diagnosis of non-small cell lung cancer, and scans showed a tumor in the upper right lung with extensive lymph-node involvement. She was diagnosed with Stage…
Read this storyStage IV Non-Small Cell Lung Cancer: Tomma’s Patient Story
Tomma Hargraves discovered a small lump on the left side of her neck in 2006. A biopsy showed non-small cell lung cancer, and scans found a tumor in her right lung with extensive lymph node involvement. Her initial diagnosis was Stage III lung cancer. Tomma…
Read this storyStage IV EGFR Non-Small Cell Lung Cancer: Ginger’s Patient Story
Ginger Tam sought care for a persistent cough and learned that she had Stage IV non-small cell lung cancer. The diagnosis was devastating for the single mother, whose daughter was 8 at the time. She sought a second opinion at a research hospital and became…
Read this storyStage IV EGFR Lung Cancer: Molly’s Patient Story
Molly Golbon was 39, a working mother and wife, when she learned that what seemed like bronchitis or pneumonia was actually Stage IV lung cancer. The diagnosis was especially shocking because she had never smoked and did not fit the stereotype she associated…
Read this storyBRCA1 Non-Small Cell Lung Cancer: Nadine’s Survivor Story
Nadine Beech was 27, healthy and a non-smoker when she was diagnosed with non-small cell lung cancer in 1997. After she started spitting up blood following a water-skiing accident, the problem was first treated as a bruised lung. Several doctors later, an 8…
Read this storyEGFR Lung Cancer Patient Story
This Noxte post was written from Asturias, where the patient had gone after an oncology visit in Majadahonda. The visit on 15 July focused on toxicity monitoring for AZD9291, the study drug he was receiving through a clinical trial. The checks were…
Read this storyLung Cancer Patient Story
This Noxte post explained how liquid biopsy was beginning to affect the patient’s lung cancer care. He had been participating in blood-based monitoring to track treatment effects and possible resistance. At an oncology visit, his doctors had the latest blood…
Read this storyLung Cancer Patient Story
By January 2016, this Spanish lung cancer blogger was marking 2 years of survival while facing a new treatment setback. Recent bronchoscopy and blood testing confirmed that the cancer had developed resistance, including the T790M mutation. That finding…
Read this storyLung Cancer Patient Story
In January 2016, this lung cancer patient learned that a recent CT scan explained his worsening cough. The scan showed clear progression: the right upper-lobe mass had grown to about 4.9 x 5 cm, with extension to the visceral pleura, involvement around the…
Read this storyEGFR Non-Small Cell Lung Cancer Patient Story
In December 2015, this patient was living with EGFR-mutated non-small cell lung cancer and taking Tarceva, also called erlotinib, which he had started in January. Much of this post reflected his effort to understand the fast-changing treatment landscape. He…
Read this storyLung Cancer Patient Story
In July 2015, this patient described a quieter summer with lung cancer. After the stress of the last CT results, time away from doctors and testing brought a sense of calm. He was spending much of the summer in Asturias and only interrupted the trip to…
Read this storyLung Cancer Patient Story
In early March 2015, this lung cancer patient was in the difficult waiting period around a CT scan. He was taking erlotinib, also known as Tarceva, and the side effects were affecting both his body and his mood. People following his blog noticed that he was…
Read this storyEGFR Non-Small Cell Lung Cancer Patient Story
By mid-February 2015, this patient had been taking Erlotinib, also known as Tarceva, for about 1.5 months for EGFR-mutated non-small cell lung cancer. He understood Tarceva as a targeted therapy for cancers with an EGFR mutation and hoped he would be among…
Read this storyLung Cancer Patient Story
In January 2015, this lung cancer patient had just started Erlotinib, also called Tarceva. He began the oral treatment on January 2 and had been taking it fasting for more than 15 days. Early side effects were already noticeable. The most visible was a mild…
Read this storyLung Cancer Patient Story
This lung cancer diary entry captures the first days after starting a new oral treatment, Erlotinib/Tarceva. The patient began the medication on January 2, 2015, and by the third pill had not yet developed major side effects. He noticed some facial itching…
Read this story